|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8525 USD | -7.62% |
|
-22.50% | -85.43% |
| 06-04 | Augmedix, Inc. Reiterates Earnings Guidance for the Second Quarter and Full Year of 2024 | CI |
| 05-29 | Augmedix Appoints Alex Stinard as Chief Clinical AI Officer | CI |
Augmedix, Inc. reported earnings results for the third quarter ended September 30, 2023. For the third quarter, the company reported sales was USD 11.77 million compared to USD 7.86 million a year ago. Net loss was USD 4.41 million compared to USD 5.49 million a year ago.
Basic loss per share from continuing operations was USD 0.1 compared to USD 0.15 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -85.43% | 45.19M | |
| +13.20% | 68.44B | |
| +6.80% | 17.28B | |
| +21.29% | 13.67B | |
| +8.24% | 13.08B | |
| +14.88% | 9.87B | |
| -20.48% | 6.92B | |
| -4.70% | 5.82B | |
| +3.43% | 5.22B | |
| +6.41% | 4.79B |
AUGMEDIX, INC. 
